You are here

Dual treatment 'of greater benefit to stroke patients'

Dual treatment 'of greater benefit to stroke patients'
13th November 2008

Stroke patients who receive a dual treatment are likely to have a better prognosis than those who receive a single therapy, a new study suggests.

People given a minimally-invasive treatment known as intravenous thrombolysis and who receive endovascular interventions – such as medicines or the implantation of medical devices – are "much more likely to recover" and have a lower risk of fatality, according to findings from the Zeenat Qureshi Stroke Research Centre at the University of Minnesota Medical School.

The results are based on a comparison of 33 stroke patients who were given the combined therapies and a control cohort of 30 patients who received only thrombolysis.

"In theory it made sense to administer both treatments, but this is the first time we have the data to support the therapeutic benefit of such an approach," commented university spokesperson Adnan Qureshi.

The results represented "objective data" to support the use of a combined therapy approach, the expert added.

A recent study conducted in the UK by the Stroke Association found that many women are unaware of simple measures they could take to lower the risk of experiencing a stroke.

The charity said that each week 110 women aged under 65 have a stroke in the UK.

Please click here for advice to help you find the right type of care.